Skip to content

A study to check effect of an Ayurvedic treatment on corona positive patients

A prospective, interventional, single group study to evaluate safety and effectiveness of an Ayurvedic regimen as an add on treatment in hospitalized SARS-CoV2 tested positive pre-symptomatic, mild or moderate COVID-19 cases - COVID-19

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026601
Enrollment
70
Registered
2020-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: An Ayurvedic regimen: Patients in study group will receive following interventions along with conventional treatment. 1. Surasadi Kadha Name of intervention: Surasadi Kadha Route of adm

Sponsors

Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals of either sex above 18 2. People who have been tested positive to be infected with SARS-CoV2 virus and presenting with no symptoms or mild to moderate symptoms. 3. Subject who agrees for giving informed consent and provide signed and dated written IEC approved Informed Consent Form (ICF) prior to initiation of any study procedures

Exclusion criteria

Exclusion criteria: 1. Subjects who are not able to or not willing to sign an IRB/IEC approved consent form. 2. COVID patients with symptoms classified as severe or critical. 3. Persons with severe primary respiratory disease or other pneumonia 4. Pregnant women 5. Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators 6. COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials

Design outcomes

Primary

MeasureTime frame
Change in result of RT-PCR test for SARS-CoV2Timepoint: Day 1 and 8

Secondary

MeasureTime frame
1. Length of time to clinical improvement 2. Percent mortality 3. Change in IgG and IgM levels in serum (Day 1 & Day 8) 4. Change in O2 Saturation 5. Defervescence of feverTimepoint: Day 1 and 8

Countries

India

Contacts

Public ContactDrShivprasad Charkha

Shri Sant Dnyaneshwar Mauli Ayurved Pratishthan, Beed

shriayurved104@gmail.com9422240104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026